Nakagawa-Goto Kyoko, Yamada Koji, Nakamura Seikou, Chen Tzu-Hsuan, Chiang Po-Cheng, Bastow Kenneth F, Wang Shao-Chun, Spohn Bill, Hung Mien-Chie, Lee Fang-Yu, Lee Fang-Chen, Lee Kuo-Hsiung
Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Bioorg Med Chem Lett. 2007 Sep 15;17(18):5204-9. doi: 10.1016/j.bmcl.2007.06.083. Epub 2007 Jul 4.
Various dietary antioxidants, including vitamins, flavonoids, curcumin, and a coumarin, were conjugated with paclitaxel (1) through an ester linkage. The newly synthesized compounds were evaluated for cytotoxic activity against several human tumor cell lines as well as the corresponding normal cell lines. Interestingly, most tested conjugates selectively inhibited the growth of 1A9 (ovarian) and KB (nasopharyngeal) tumor cells without activity against other cell lines. Particularly, conjugates 16 and 20 were highly active against 1A9 (ED(50) value of 0.005 microg/mL) as well as KB (ED(50) values of 0.005 and 0.14 microg/mL, respectively) cells. Compound 22b, the glycinate ester salt of vitamin E conjugated with 1, appears to be a promising lead for further development as a clinical trial candidate as it exhibited strong inhibitory activity against Panc-1 (pancreatic cancer) with less effect on the related E6E7 (normal) cell line.
多种膳食抗氧化剂,包括维生素、类黄酮、姜黄素和一种香豆素,通过酯键与紫杉醇(1)共轭。对新合成的化合物针对几种人类肿瘤细胞系以及相应的正常细胞系进行了细胞毒性活性评估。有趣的是,大多数测试的共轭物选择性地抑制1A9(卵巢)和KB(鼻咽)肿瘤细胞的生长,而对其他细胞系无活性。特别是,共轭物16和20对1A9(ED(50)值为0.005微克/毫升)以及KB(ED(50)值分别为0.005和0.14微克/毫升)细胞具有高活性。化合物22b,即与1共轭的维生素E甘氨酸酯盐,似乎是作为临床试验候选物进一步开发的有前景的先导物,因为它对Panc-1(胰腺癌)表现出强抑制活性,而对相关的E6E7(正常)细胞系影响较小。